Bio Protocol vs ELIZAOS — how do they compare? Bio Protocol trades at Rp439.86 (market cap Rp996,26M, Rp160,17M 24h volume), while ELIZAOS trades at Rp3.99 (market cap Rp38,21M, Rp126,73M 24h volume). The key difference: Bio Protocol is far larger — about 26.1× ELIZAOS's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 9,5B / 11B ELIZAOS (87%) for ELIZAOS. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and ELIZAOS for 8 Days on average.
| BIO | ELIZAOS | |
|---|---|---|
Market Cap | Rp996,26M | Rp38,21M |
Volume (24h) | Rp160,17M | Rp126,73M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 9,5B / 11B ELIZAOS (87%) |
Typical Hold Time | 18 Days | 8 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
ELIZAOS is trading at Rp4.11 with a market cap of Rp38.85M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 87% of its maximum 11M supply in circulation with an average hold time of 8 days. Current technical analysis indicates weak momentum with RSI levels showing mixed signals and ADX suggesting strong trend direction.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential oversold conditions indicated by RSI_12 at 27.40. Major risks include low liquidity, high volatility, and limited exchange support. Investors should monitor for protocol updates and increased trading volume as potential catalysts.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →elizaOS is an open-source framework for building autonomous AI agents that can read data, make decisions, and take action across blockchains and the web. In its latest version, agents are built from modular plugins, enabling workflows that connect wallets, DeFi protocols, off-chain APIs, and messaging channels.
Read more on ELIZAOS →